Infobox person name Johnny Gunther imagesize 175px caption birth date November 4, 1929 birth place Paris , France death date death date and age 1947 6 30 1929 11 4 death place New York , New York education Deerfield Academy occupation student residence spouse children parents John Gunther and Frances Gunther religion John Gunther jr November 4, 1929 June 30, 1947 , was the son of the American author John Gunther and is the central figure in John Gunther s book, Death Be Not Proud book Death Be Not Proud , which tells of the younger Gunther s death at the age of seventeen from a brain tumor . ref John Gunther, Death Be Not Proud 1949 . Harper Perennial edition 1998 ISBN 0 06 092989 8 ref Born in 1929 in Paris, France , Gunther was diagnosed with a brain tumour, later further diagnosed as glioblastoma multiforme , at age 16 and died from the illness 15 months later at Memorial Sloan Kettering Cancer Center Memorial Hospital , now known as Memorial Sloan Kettering Cancer Center, in New York City . ref cite news url http select.nytimes.com gst abstract.html?res F50F14FA3A5A147B93C0A9178CD85F438485F9 title JOHN GUNTHER JR. format pdf work The New York Times pages 23 date July 2, 1947 ref ref http muse.jhu.edu cgi bin access.cgi?uri journals bulletin of the history of medicine v078 78.4krueger.html Abstract of Krueger, Gretchen Marie Death Be Not Proud Children, Families, and Cancer in Postwar America Bulletin of the History of Medicine Volume 78, Number 4, Winter 2004, pp. 836 863 ref In his father s memoir, Johnny Gunther s struggle against the disease is documented and he is described as a very talented young man by all who knew him the sharpness of his intellect is evidenced by the fact that he corresponded briefly with Albert Einstein about physics before his illness prevented him from continuing his academic pursuits. Immediately before his death Gunther realized his dream of living long enough to graduate from University preparatory school prep school at Deerfield ... more details
John Andrew Durrant Olle 28 December 1947 spaced ndash 12 December 1995 , always known as Andrew Olle , was a radio and television presenter on the Australian Broadcasting Corporation , beginning his career in 1967 as a news cadet and, until his death, working in a wide variety of programs, including The 7.30 Report , 2BL ABC Radio 2BL, Sydney , Nationwide , Four Corners TV program Four Corners and A Big Country . Andrew Olle died in 1995 from a brain tumour glioblastoma multiforme which was not diagnosed until he was rushed to hospital following a massive stroke and collapse. He never regained consciousness and died within a week, on 12 December. On 13 December, in the NSW State Parliament, the Premier of New South Wales Bob Carr , himself a former ABC journalist, moved a formal condolence motion on Olle s death. ref http www.parliament.nsw.gov.au prod parlment hansart.nsf V3Key LA19951213025 Parliament of New South Wales ref For his Memorial Service in the Sydney Town Hall on 22 December, Peter Sculthorpe wrote a special arrangement for cello and piano of his 1947 work Parting , dedicated to Olle, which was played by Nathan Waks and Kathryn Selby . ref http www.australianmusiccentre.com.au workversion sculthorpe peter parting 10444 Australian Music Centre ref Legacy The Andrew Olle Memorial Trust was established to raise money for brain cancer and neurosurgery research. The Andrew Olle Media Lecture is an annual lecture held by the ABC in his honour. Sources About Andrew Olle , Australian Broadcasting Corporation, 15 October 2003 http www.abc.net.au local stories 2003 10 15 285463.htm Helen Pitt, A cancer with still no cure in mind , Sydney Morning Herald, 12 December 2005 http www.smh.com.au news national a cancer with still no cure in mind 2005 12 11 1134235951361.html References reflist Persondata Metadata see Wikipedia Persondata . NAME Olle, Andrew ALTERNATIVE NAMES SHORT DESCRIPTION DATE OF BIRTH 28 December 1947 PLACE OF BIRTH DATE OF DEATH 12 December 1995 ... more details
Chembox ImageFileL1 Nitrosourea.png ImageFileL1 Ref chemboximage correct ?? ImageSizeL1 121 ImageNameL1 Skeletal formula of a minor tautomer of nitrosourea ImageFileR1 Nitrosourea 3D balls.png ImageFileR1 Ref chemboximage correct ?? ImageSizeR1 121 ImageNameR1 Ball and stick model a minor tautomer of nitrosourea IUPACName Nitrosourea Section1 Chembox Identifiers CASNo 13010 20 3 CASNo Ref cascite changed ?? PubChem 105035 PubChem Ref Pubchemcite correct PubChem ChemSpiderID 94772 ChemSpiderID Ref chemspidercite correct chemspider SMILES NC O N NO SMILES1 C O N NN O StdInChI 1S CH3N3O2 c2 1 5 3 4 6 h H3,2,3,5,6 StdInChI Ref stdinchicite correct chemspider StdInChIKey OSTGTTZJOCZWJG UHFFFAOYSA N StdInChIKey Ref stdinchicite correct chemspider Section2 Chembox Properties C 1 H 3 N 3 O 2 ExactMass 89.022526355 g mol sup 1 sup Image Urea.png thumb 240px Urea Image Streptozotocin Structure NTP.png thumb 240px Streptozotocin Image Ethylnitrosourea.svg thumb 240px ENU Nitrosourea is both the name of a molecule, and a class of compounds that include a nitroso R NO group and a urea . Examples Examples include Carmustine Lomustine Semustine Ethylnitrosourea ENU Streptozotocin Nitrosourea compounds are DNA alkylating antineoplastic agent alkylating agents and are often used in chemotherapy . ref name urlantineop cite web url http faculty.swosu.edu scott.long phcl antineop.htm title Antineop format work accessdate 2009 01 24 ref They are lipophile lipophilic and thus can cross the blood brain barrier , making them useful in the treatment of brain tumor s such as glioblastoma multiforme . ref Takimoto CH, Calvo E. http www.cancernetwork.com cancer management 11 chapter03 article 10165 1402628 Principles of oncologic pharmacotherapy . in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ Eds http www.cancernetwork.com cancer management 11 Cancer management a multidisciplinary approach . 11 ed. 2008. ref Side effects Some nitrosoureas e.g. lomustine have been associated with the develo ... more details
Acridine carboxamide N 2 dimethylamino ethyl acridine 4 carboxamide is an chemotherapy agent that is being studied in the treatment of cancer . It belongs to the family of drugs called topoisomerase inhibitor s. While the agent was well tolerated in Phase II clinical trial s, it did not show efficacy when tested against various types of cancers. ref cite journal author Dittrich C title Phase II study of XR5000 DACA , an inhibitor of topoisomerase I and II, administered as a 120 h infusion in patients with advanced ovarian cancer journal Investigational new drugs volume 21 issue 3 pages 347 52 year 2003 pmid 14578683 doi 10.1023 A 1025476813365 author separator , author2 Dieras V author3 Kerbrat P display authors 3 last4 Punt first4 Cornelis last5 Sorio first5 Roberto last6 Caponigro first6 Francesco last7 Paoletti first7 Xavier last8 De Balincourt first8 Christine last9 Lacombe first9 Denis ref ref cite journal author Caponigro F title Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer journal Eur. J. Cancer volume 38 issue 1 pages 70 4 year 2002 pmid 11750842 doi 10.1016 S0959 8049 01 00336 7 author separator , author2 Dittrich C author3 Sorensen JB display authors 3 last4 Schellens first4 JH last5 Duffaud first5 F last6 Paz Ares first6 L last7 Lacombe first7 D last8 De Balincourt first8 C last9 Fumoleau first9 P ref ref cite journal author Twelves C title Phase II study of XR5000 DACA administered as a 120 h infusion in patients with recurrent glioblastoma multiforme journal Ann. Oncol. volume 13 issue 5 pages 777 80 year 2002 pmid 12075748 doi 10.1093 annonc mdf121 author separator , author2 Campone M author3 Coudert B display authors 3 last4 Van Den Bent first4 M last5 De Jonge first5 M last6 Dittrich first6 C last7 Rampling first7 R last8 Sorio first8 R last9 Lacombe first9 D ref ref cite journal author Dittrich C title Phase II study of XR 5000 DACA , an inhibitor of topoisomerase I and II, administered as a 120 h ... more details
Use dmy dates date November 2011 Use Australian English date November 2011 Image Beazleypressconf.JPG thumb 250px right Matt Price in the background in the purple shirt , watches Kim Beazley at a press conference in November 2005. for the Australian ice hockey player Matthew Price ice hockey Matt Price 15 October 1961 &ndash 25 November 2007 was a Western Australia n journalist and newspaper columnist. He was educated at Newman College, Perth Newman College , Churchands and the University of Western Australia , from which he graduated with a Bachelor of Arts in 1984. He covered federal politics as a member of the Canberra Press Gallery for The Australian newspaper, writing a regular column entitled The Sketch , that often took a humorous view of parliamentary proceedings. He also occasionally wrote about sport. He was a regular guest on the Insiders TV program Insiders program. He formerly worked in television, including stints at Nine Network Channel Nine and Sky News . Previously, he worked for the Albany Advertiser and Perth s Daily News Perth Daily News . In early October 2007, Price was diagnosed with multiple Brain tumor brain tumours i.e. glioblastoma multiforme . ref http www.theaustralian.news.com.au story 0,25197,22548832 22822,00.html Article in The Australian newspaper about brain cancer diagnosis The Australian ref He died on 25 November 2007 ref http blogs.theaustralian.news.com.au mattprice index.php theaustralian comments journalist matt price dies aged 46 Obituary in The Australian Journalist Matt Price dies aged 46 The Australian ref . Prime Minister elect Kevin Rudd said of his death that I am shocked and deeply saddened by the news of Matt Price s death. He had emerged in recent years as one of the greats of the new generation of Australian journalists. ref http www.news.com.au heraldsun story 0,21985,22820345 662,00.html?from mostpop Colleagues mourn journalist Matt Price death The Herald Sun ref ref http www.news.com.au heraldsun story 0,21985, ... more details
MedAbbrev F H class wikitable sortable Sortable table scope col Abbreviation scope col Meaning G gravidity total number of pregnancies, successful or not br guanosine G6PD glucose 6 phosphate dehydrogenase GA general anaesthesia br gestational age GABA gamma aminobutyric acid GABHS group A beta hemolytic streptococcus GB gallbladder GBC gallbladder carcinoma GBS group B Strep. br Guillain Barr syndrome GBM glioblastoma multiforme br glomerular basement membrane GC general condition br Neisseria gonorrhoeae gonococcus GCA Temporal arteritis giant cell arteritis GCS Glasgow Coma Scale GCT glucose challenge test G CSF granulocyte colony stimulating factor GDA gastroduodenal artery GDLH glutamate dehydrogenase GDM gestational diabetes GDP guanosine diphosphate GERD gastroesophageal reflux disease GFR glomerular filtration rate GGT gamma glutamyl transferase GGTP gamma glutamyl transpeptidase GH growth hormone GHRF growth hormone releasing factor GHRH growth hormone releasing hormone GI gastrointestinal br Human gastrointestinal tract gastrointestinal tract GIFT gamete intrafallopian transfer GIST gastrointestinal stromal tumor GIT Human gastrointestinal tract gastrointestinal tract GITS Pill splitting gastrointestinal therapeutic system GMC general medical condition e.g., 0 GMC GM CSF granulocyte macrophage colony stimulating factor GMP guanosine monophosphate GN glomerulonephritis GNRH gonadotropin releasing hormone GOAT Galveston Orientation and Amnesia Test GOD glucose oxidase GOK God only knows GOMER get outta my ER GORD gastroesophageal reflux disease gastro oesophageal reflux disease GOT glutamic oxalacetic transaminase GP general practitioner br Goodpasture s syndrome GPT glutamic pyruvic transaminase Gr Grain mass grain GRAV I gravidity 1 indicating a woman during her first pregnancy GSW gunshot wound GTN glyceryl trinitrate pharmacology glyceryl trinitrate br gestational trophoblastic neoplasia GTT glucose tolerance test br gestational trophoblastic tumor Gtts ... more details
Orphan date April 2010 Infobox company company logo Deleted image removed Image Save A Brain Foundation Logo.jpg 230px deletable image caption 1 Monday, 28 September 2009 company name Save A Brain Foundation parent company type Non Profit company slogan foundation 2008 in Los Angeles, California founder George Kohan, Isaac Meier, Samuel Zidovetzki location key people homepage http www.saveabrain.org SaveABrain.org The Save A Brain Foundation is a is a 501 c 3 non profit organization with the goals of raising awareness of Glioblastoma Multiforme , the most common type of primary brain tumor, as well as raising money in hopes of finding a cure for this terminal disease ref cite web url http www.saveabrain.org mission.html title Save A Brain Foundation Mission Page ref . To date, the foundation has raised tens of thousands of dollars for brain cancer research. Origin The plan to establish the foundation came about in January 2008, after three friends who had recently graduated from the University of Southern California decided to create the foundation as a means of helping combat GBM. The cofounders of the foundation are George Kohan, Isaac Meier, and Samuel Zidovetzki ref http saveabrain.org aboutus.html ref . At the time, Isaac s father had recently been diagnosed with GBM, which served as the impetus for the establishment of the foundation. Fundraising Events The foundation has hosted multiple fundraising events throughout the United States, including notable events in New York and California . One of the foundation s first major fundraising events, Bowling for Brains , was hosted in April 2009 at the Lucky Strike Lanes in Manhattan, New York Manhattan , New York . This event served as the first substantial opportunity for the foundation to make its existence and goals known to the general public. The success of this event ensured its recurrence on an annual basis for years to come. Another notable fundraising event took place on September 3, 2009 at the Hollywood B ... more details
therapy has not been fully tested. IV Glioblastomamultiforme GBM Consists of Glioblastomamultiforme ... George Gershwin with a glioblastomamultiforme in 1937. However, recent studies indicate that this diagnosis ... glioma astrocytomas.html . GlioblastomaMultiforme Treatment at Mayo Clinic. Mayo Clinic Medical ... makes complete surgical removal impossible. Although radiotherapy rarely cures glioblastoma ... more details
, and glioblastomamultiforme of the brain. At one point bevacizumab was approved for breast cancer by the FDA ... accelerated approval of Avastin for the treatment of recurrent glioblastomamultiforme in May 2009. ref cite web url http www.cancer.gov cancertopics druginfo fda bevacizumab Anchor Glioblastoma ... 2010 ref and glioblastomamultiforme , ref cite journal first1 T. F. last1 Cloughesy first2 M. D. last2 ... February 28, 2012 ref See also glioblastomamultiforme metastatic breast cancer angiogenesis colorectal ..., lung, breast outside the USA , glioblastoma USA only , kidney and ovarian. Bevacizumab is a humanized ... as an approved treatment for certain types of colon, lung, kidney and brain cancer glioblastomamultiforme . ref cite press release title FDA Commissioner announces Avastin decision Drug not to be safe ... cancer glioblastoma that has progressed following prior therapy Genentech, Inc. FDA Grants Accelerated Approval of Avastin for Brain Cancer Glioblastoma That Has Progressed Following Prior Therapy . Market ... reported that Avastin improves response and survival in patients with recurrent glioblastoma ... intra arterially directly into the brain tumors of fourteen patients with recurrent glioblastomamultiforme . Results were sufficiently encouraging to propose a Phase II trial of the technique. ref ... of bevacizumab after blood brain barrier disruption for the treatment of recurrent glioblastoma progression ... glioblastoma GBM journal Journal of Clinical Oncology volume 26 issue 15S pages 2010b url http meeting.ascopubs.org ... more details
but, after a brief period of time returned to the States. De Mae was diagnosed with glioblastomamultiformeglioblastoma , an aggressive form of brain cancer in July 2004. ref cite web url http business.avn.com ... more details
Orphan date February 2009 PBB geneid 83596 Bcl 2 like protein 12 is a protein that in humans is encoded by the BCL2L12 gene . ref name entrez cite web title Entrez Gene Bcl2L12 Bcl2 like 12 proline rich url http www.ncbi.nlm.nih.gov sites entrez?Db gene&Cmd ShowDetailView&TermToSearch 83596 accessdate ref ref name pmid11401436 cite journal author Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP title Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline rich protein with a highly conserved BH2 domain of the Bcl 2 family journal Genomics volume 72 issue 2 pages 217 21 year 2001 month March pmid 11401436 doi 10.1006 geno.2000.6455 url ref The protein encoded by this gene belongs to the Bcl 2 protein family. Bcl 2 family members form heterodimer hetero or homodimers and act as anti or pro apoptotic regulators that are involved in a wide variety of cellular activities. This protein contains a Bcl 2 homology domain 2 BH2 . The function of this gene has not yet been determined. Two Alternative splicing alternatively spliced Transcription genetics transcript variants of this gene encoding distinct isoforms have been reported. ref name entrez Bcl2L12 expression is upregulated in most human glioblastoma multiforme glioblastomas . Expression of Bcl2L12 results in resistance to apoptosis . Bcl2L12 directly neutralizes caspase 7 CASP7 and indirectly neutralizes caspase 3 CASP3 by an indirect mechanism. ref name pmid17210792 cite journal author Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN, DePinho RA, Chin L title Bcl2L12 inhibits post mitochondrial apoptosis signaling in glioblastoma journal Genes Dev. volume 21 issue 1 pages 98 111 year 2007 month January pmid 17210792 pmc 1759904 doi 10.1101 gad.1480007 url ref Both caspase enzymes are known to play essential roles in the execution phase of apoptosis. ref name pmid10200519 cite journal author Wils ... more details
glioblastomamultiforme , five had or have oligodendroglioma , two had or have meningioma , and one ... have died, six from glioblastomamultiforme. The story has been covered in depth by the local ... more details
microarray data indicates that CARKD is up regulated in Glioblastomamultiforme tumors. ref name pmid17002787 ... of Glioblastomamultiforme tumors detected by expression and CGH microarray profiling journal ... more details
Infobox person name Ivan Noble image Ivan Noble BBC Journalist.jpg caption Ivan Noble birthname birth date June 1967 birth place Leeds , England death date death date and age df yes 2005 1 31 1967 6 30 death place London , England education occupation translator, journalist alias title family spouse Almut domestic partner children one son, one daughter relatives ethnicity nationality religion years active 1990 2005 credits agent URL Use dmy dates date August 2010 Ivan Noble June 1967 &ndash 31 January 2005 was a Media in the United Kingdom British journalist who worked for BBC News Online and became well known for his diary documenting his fight against cancer . Born in Leeds , he lived in East Germany working as a translator between 1988 and 1990. He then joined the BBC, originally working for them as a translator, then as a sub editor in Nairobi , before working in the Science and Technology section of the BBC News website, where he was known for his love of complicated gadgetry. He was diagnosed with glioblastoma multiforme on 29 August 2002, and wrote about his battle against the cancer on the BBC News website in a series entitled Tumour Diary . Noble continued to write stories for the series until 30 January 2005, the day before he died. The tumour left him with serious visual impairment s on the right side. In December 2004, having completed several courses of chemotherapy , and after a brief remission medicine remission , his tumour started to grow again. Noble enjoyed a huge amount of public support during this period. His final comment before his death ended with the statement I will end with a plea. I still have no idea why I ended up with a cancer, but plenty of other cancer patients know what made them ill...If two or three people stop smoking as a result of anything I have ever written then the one of them who would have got cancer will live and all my scribblings will have been worthwhile. Noble died in a London Hospice care hospice aged 37. He was sur ... more details
Drugbox verifiedrevid 419432832 IUPAC name N isopropyl 4 2 methylhydrazino methyl benzamide image Procarbazine.svg width 180px Clinical data tradename Matulane Drugs.com drugs.com monograph procarbazine hydrochloride MedlinePlus a682094 pregnancy AU D pregnancy US D legal status Rx only routes of administration Oral Gel Capsule , Intravenous therapy intravenous Pharmacokinetic data bioavailability ? metabolism Hepatic , Renal elimination half life 10 minutes excretion Renal Identifiers CASNo Ref cascite correct CAS CAS number 671 16 9 ATC prefix L01 ATC suffix XB01 PubChem 4915 DrugBank Ref drugbankcite correct drugbank DrugBank DB01168 ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID 4746 UNII Ref fdacite correct FDA UNII 35S93Y190K KEGG Ref keggcite correct kegg KEGG D08423 ChEMBL Ref ebicite correct EBI ChEMBL 1321 Chemical data C 12 H 19 N 3 O 1 molecular weight 221.299 Gram g Mole unit mol smiles O C c1ccc cc1 CNNC NC C C InChI 1 C12H19N3O c1 9 2 15 12 16 11 6 4 10 5 7 11 8 14 13 3 h4 7,9,13 14H,8H2,1 3H3, H,15,16 InChIKey CPTBDICYNRMXFX UHFFFAOYAK StdInChI Ref stdinchicite correct chemspider StdInChI 1S C12H19N3O c1 9 2 15 12 16 11 6 4 10 5 7 11 8 14 13 3 h4 7,9,13 14H,8H2,1 3H3, H,15,16 StdInChIKey Ref stdinchicite correct chemspider StdInChIKey CPTBDICYNRMXFX UHFFFAOYSA N Procarbazine Matulane US , Natulan Canada , Indicarb India is an antineoplastic chemotherapy drug for the treatment of Hodgkin s lymphoma and certain brain cancers such as Glioblastoma multiforme . It is a member of a group of medicines called alkylating antineoplastic agent alkylating agents . It gained FDA Approved in July 1969. The drug is metabolized and activated in the liver. It also inhibits Monoamine oxidase MAO thus increasing the effects of sympathomimetics , tricyclic antidepressant TCA s, and tyramine . Pharmacology Its mechanism of action is not fully understood. Metabolism yields azo procarbazine and hydrogen peroxide Citation needed date August 2010 which resul ... more details
Fibrillary astrocytomas also called low grade or diffuse astrocytoma s, are a group of primary tumor primary slow growing brain tumor s. They typically occur in adults between the ages of twenty and fifty. cn date September 2011 Pathology Fibrillary astrocytomas arise from neoplasm neoplastic astrocyte s, a type of glial cell found in the central nervous system. They may occur anywhere in the brain, or even in the spinal cord ref name lga http emedicine.medscape.com article 1156429 overview ref , but are most commonly found in the cerebral hemispheres. As the alternative name of diffuse astrocytoma implies, the outline of the tumour is not clearly visible in scans, because the borders of the neoplasm tend to send out tiny microscopic fibrillary tentacles that spread into the surrounding brain tissue. These tentacles intermingle with healthy brain cells, making complete surgical removal difficult. However, they low grade tumors, with a slow rate of growth, so that patients commonly survive longer than those with otherwise similar types of brain tumour, such as glioblastoma multiforme . ref name lga Symptoms and diagnosis Seizure s, frequent mood changes, and headaches are among the earliest symptoms of the tumor. Hemiparesis , or physical weakness on one side of the body, is also common. ref name lga A continuous Electroencephalography EEG recording of the brain s electrical activity may help to identify and localize seizure activity, especially in children. X ray computed tomography CT scan s and Magnetic resonance imaging MRI scan s of the brain may show the presence of a diffuse mass that fails to light up when a contrast dye is given. cn date September 2011 In some cases, a biopsy may be required to confirm the nature of the tumour. Treatment Treatment options include surgery , radiotherapy , radiosurgery , and chemotherapy . The infiltrating growth of microscopic tentacles in fibrillary astrocytomas makes complete surgical removal difficult or impossible without ... more details
. Reference necessary 1 Glioblastomamultiforme and astrocytoma anaplastic astrocytoma have been associated ... nervous system, e.g. bone metastasis of glioblastomamultiforme . ref cite journal author1 Frappaz ... with a diagnosis of glioblastomamultiforme. They are the only institution in the United ... resection while glioblastomamultiforme has a median survival of only 12 months even with aggressive ... prognosis and long term survival has frequently been reported. Glioblastomamultiforme Main GlioblastomamultiformeGlioblastomamultiforme is the deadliest and most common form of malignant ... I II trial for the potential treatment of recurrent high grade glioma including glioblastomamultiforme ... Chassagne Clement C. author7 Thiesse P. author8 Mere P. author9 Deruty R. title Bone metastasis of glioblastomamultiforme confirmed by fine needle biopsy journal Acta neurochirurgica Wien volume 141 ..., and surgical excision is used, median survival is only 12 17 months. Standard therapy for glioblastomamultiforme consists of maximal surgical Segmental resection resection of the tumor, followed by radiotherapy .... This is followed by temozolomide chemotherapy . Most patients with glioblastoma take a corticosteroid ... independent studies have identified many more types susceptible to the virus, including glioblastomamultiforme cancer cells, which account for the majority of brain tumors. In 2008, researchers artificially ... to Subjects With Recurrent Glioblastoma GBM ref In children Image Tumor BrainstemGlioma2.JPG thumb ... more details
Encyclopedia
top
